ITGAE and neoplasm: The CD103+CD39+CD8+ TRM cells in tumor implants tended to have higher PD-1 and LAG-3 expression than CD103+CD39−CD8+ TRM cells (Figure 4B), suggesting the possibility of distinguishing the activation state of TRM cells via CD39 expression.